Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization

Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cell Death Dis
Auteurs principaux: Wang, Shuo, Zhang, Chao, Li, Jiawei, Niyazi, Sidikejiang, Zheng, Long, Xu, Ming, Rong, Ruiming, Yang, Cheng, Zhu, Tongyu
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477572/
https://ncbi.nlm.nih.gov/pubmed/28383559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.104
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires